RU93033547A - METHOD OF TREATMENT OF PURULENT ARTHRITIS - Google Patents

METHOD OF TREATMENT OF PURULENT ARTHRITIS

Info

Publication number
RU93033547A
RU93033547A RU93033547/14A RU93033547A RU93033547A RU 93033547 A RU93033547 A RU 93033547A RU 93033547/14 A RU93033547/14 A RU 93033547/14A RU 93033547 A RU93033547 A RU 93033547A RU 93033547 A RU93033547 A RU 93033547A
Authority
RU
Russia
Prior art keywords
treatment
joint
purulent arthritis
vitacin
introduction
Prior art date
Application number
RU93033547/14A
Other languages
Russian (ru)
Inventor
С.С. Фейгельман
Original Assignee
Товарищество с ограниченной ответственностью "Адамант"
Filing date
Publication date
Application filed by Товарищество с ограниченной ответственностью "Адамант" filed Critical Товарищество с ограниченной ответственностью "Адамант"
Publication of RU93033547A publication Critical patent/RU93033547A/en

Links

Claims (1)

Лечение гнойных артритов, как правило, требует вскрытия сустава, его дренирования с последующим введением антисептических средств. Лечение длительное и нередко заканчивается контрактурой больного сустава. Предлагаемый способ лечения гнойных артритов заключается в введении в пораженный сустав раствора витацина, обладающего высокой некролитической и фибринолитической активностью, а также подавляющего рост гноеродных микробов, в том числе устойчивых к антибиотикам, позволяет обойтись без операции. Расплавление фибринозных свертков витацином предупреждает возникновение неподвижности в суставе.Treatment of purulent arthritis, as a rule, requires the opening of the joint, its drainage with the subsequent introduction of antiseptic agents. The treatment is long and often results in contracture of the affected joint. The proposed method for the treatment of purulent arthritis is the introduction into the affected joint of a solution of vitacin, which has a high necrolytic and fibrinolytic activity, and also suppresses the growth of pyogenic microbes, including those resistant to antibiotics, allows you to do without surgery. The melting of fibrinous convolutions by Vitacin prevents the formation of stiffness in the joint.
RU93033547/14A 1993-07-05 METHOD OF TREATMENT OF PURULENT ARTHRITIS RU93033547A (en)

Publications (1)

Publication Number Publication Date
RU93033547A true RU93033547A (en) 1996-04-10

Family

ID=

Similar Documents

Publication Publication Date Title
AU8155894A (en) Methods of inhibiting thrombin
CA2081703A1 (en) Thrombin and method of producing the same
EP0407008A3 (en) Fibronectin fragment
NO168539C (en) MOLDING FOR MOLDING IRON.
ES2172525T3 (en) INHIBITION OF UTERINE FIBROSIS.
DE69429336T2 (en) Composition of plant growth accelerator
RU94008616A (en) 2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS
ATE150307T1 (en) INHIBITING SEBORRHEA AND ACNE
ATE178798T1 (en) USE BEFORE SIMPLE OR CONJUGATED DEXTRAN IN THE PRODUCTION OF A MEDICATION TO PREVENT OR REDUCE THE RISK OF A BACTERIAL PATHOGENIC INFECTION
ATE220323T1 (en) METHOD OF TREATING RESISTANT NEOPLASMS
AU7891791A (en) Method of rearranging and encoding fuzzy inference rules, and method of processing fuzzy inference conforming to the rules
BR9105857A (en) CORINEBACTERIA INTEGRON, PROCESS OF TRANSFORMATION OF A BACTERIA STRAIN WITH CHORINEFORM AND CORINEBACTERIA
RU93033547A (en) METHOD OF TREATMENT OF PURULENT ARTHRITIS
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
PT740657E (en) 4-ARIL-ISOINDICS WITH ANALGESIC ACTIVITY
RU93004798A (en) NEW AZETIDINE DERIVATIVES
IT1248592B (en) DETOXIFICATION OF VEGETATION WATERS
FR2665016B1 (en) PERMANENT MAGNETS FOR THE MAGNETIC TREATMENT OF PLANTS OR THE LIKE.
RU99126370A (en) METHOD FOR TREATING SECONDARY GLAUCOMA WITH VITREAL UNIT
RU96110609A (en) METHOD FOR TREATING POST-TRAUMATIC INNER-EYE INFECTION
RU92001926A (en) CRYOAPPLICATOR
FR2708415B1 (en) Treatment of seeds with phosphorous acid or one of its salts, and seeds thus treated.
MX9800306A (en) Fungicidal mixtures.
MY105242A (en) Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles.